Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3877
-0.0104 (-2.61%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $17.18 million as of April 24, 2025. Its market cap has decreased by -91.45% in one year.

Market Cap
17.18M
Enterprise Value
57.57M
1-Year Change
-91.45%
Ranking
Category
Stock Price
$0.39

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $17.18M, a decrease of -90.10%. That is a compound annual growth rate of -9.14%.

History

DateMarket Cap% Change
Apr 24, 202517.20M-81.30%
Dec 31, 202492.00M-59.72%
Dec 29, 2023228.40M97.92%
Dec 30, 2022115.40M-59.89%
Dec 31, 2021287.70M72.07%
Dec 31, 2020167.20M44.01%
Dec 31, 2019116.10M-2.11%
Dec 31, 2018118.60M3.04%
Dec 29, 2017115.10M9.83%
Dec 30, 2016104.80M-11.04%
Dec 31, 2015117.80M-35.91%
Dec 31, 2014183.80M26.15%
Dec 31, 2013145.70M15.45%
Dec 31, 2012126.20M14.42%
Dec 30, 2011110.30M-4.42%
Dec 31, 2010115.40M9.70%
Dec 31, 2009105.20M29.08%
Dec 31, 200881.50M-42.24%
Dec 31, 2007141.10M-9.96%
Dec 29, 2006156.70M15.56%
Dec 30, 2005135.60M-3.49%
Dec 31, 2004140.50M-47.56%
Dec 31, 2003267.90M170.88%
Dec 31, 200298.90M-62.67%
Dec 31, 2001264.90M52.68%
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 767.33B
UnitedHealth Group 388.01B
Johnson & Johnson 372.44B
AbbVie 320.24B
Novo Nordisk 276.62B
Abbott Laboratories 225.41B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings